Compass Therapeutics, Inc. · NASDAQ:CMPX
BlackRock, Inc. reported a 5.20% stake in Compass Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 5.20% stake in Compass Therapeutics, Inc., 9,271,644 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 9,271,644
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.20% | 9,271,644 |
Source
Related
- Compass Therapeutics, Inc.
- BlackRock, Inc.
- Compass Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 16, 2025
- Schedule 13G · BlackRock, Inc. · Feb 4, 2025
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · May 15, 2026